Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

SONBearishAnalyst Ratingnews

Medium materiality6/10

BofA Downgrades Sonoco to Neutral; Target Cut to $60, Near-Term Pressure

Sep 3, 2026, 9:10 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Downgrade to Neutral from Buy can trigger short-term selling pressure; however, the new target above current price offers limited upside; historical precedent shows mixed moves after rating downgrades on mid-cap names, with volatility in days following the release.

AI summary

What happened, with direct paths to the underlying reporting

Analysts issued rating changes across several names, led by BofA. Sonoco (SON) is cut to Neutral with a $60 target from $69; the stock closed near $54.74. The downgrade signals near-term pressure, though the target implies potential upside if fundamentals hold.

BofA downgrades Sonoco to Neutral; price target to $60. Stock closed at $54.74 Wednesday.
Near-term SON downside risk; may test the low-50s.
Target implies modest upside to ~60 versus current price.
Analysts also downgraded Ultragenyx and Moderna in the same round.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.